Biometric ring manufacturer Oura postponed its initial public offering (IPO) on Tuesday due to "uncertainties" in the market environment, despite the company claiming there was "strong demand" for its shares. This move has drawn attention from Wall Street.

Analysts indicate that the delay of IPO is accelerating in 2026, although Oura also faces some company-level doubts from the market. Due to the soaring bond yields, the new share issuance environment for companies planning to go public has suddenly become a hindrance.

IPO Professional Institution Renaissance Capital Senior Strategist Matthew Kennedy said to CNBC: "We've had three or four instances in a row of delays – a series of postponements – and I think that indeed indicates something about the market situation. You really can't attribute all of these to problems within the company itself."

According to the data from Renaissance Capital, over the past week, four companies from different sectors that were planning to raise at least $50 million in financing announced the postponement of their IPO or directly withdrew their listing applications. This has increased the number of related cases in the third quarter to seven, compared to four in the second quarter and three in the first quarter.

Before the postponement of its listing on Oura Tuesday, nuclear power component manufacturer Holtec Nuclear withdrew its IPO last Friday; materials company Amaero postponed its IPO last Wednesday; while Bamboo Insurance postponed its IPO on September 22.

The person in charge of the IPO Initiative School of Business at the University of Florida, Warrington, stated: “I have some sympathy for using the market environment as an excuse. Since three well-known companies are doing it, it indeed indicates that this is not a problem unique to those companies.”

IPO Still maintains a stable performance for the year

Data from Renaissance Capital shows that this year, IPO has continued to perform steadily. Excluding special purpose acquisition companies ( SPAC ), there have been approximately 110 transactions, raising about 146.9 billion US dollars. This includes the large-scale offerings in the second quarter by SpaceX and South Korean memory chip manufacturer SK Hynix.

However, this figure has decreased by 30% compared to the same period last year. Throughout 2025, there were a total of 202 IPO, which is the highest number since 2021; that year, there were nearly 400. Due to the issuance of SpaceX, SK Hynix, and Cerebras, the total funds raised this year have increased by 394% year-on-year.

Looking at the industry from the beginning of the year to now, the healthcare and industrial sectors rank first in IPO quantity, each accounting for 24% of the total; the technology sector comes in third, accounting for 18%.

As of now, in 2026, 59% of all issued stocks are trading at or above the IPO issue price. However, it is worth noting that SpaceX, SK (Hynix), and Cerebras have performed below their issue prices.

Macroeconomic headwinds

Recently, macroeconomic factors and concerns regarding the development of artificial intelligence have been suppressing the new share issuance market.

Renaissance Analysts wrote in a client report last week: 'Due to heightened concerns about AI spending, bond yields rising to 19-year highs, and the resumption of interest rate hikes, IPO activity in the third quarter of 2026 fell short of expectations, dragging down the recovery in the autumn.'

Renaissance IPO ETF reached its peak in June of this year, when it was listed on SpaceX.

DA Davidson, the head of technical research, stated: "In areas related to AI, including large-scale infrastructure construction, there is still a high level of enthusiasm. There is a great demand in fields such as data centers, but to a large extent, this is a commodity-like business."

Analysts say that Oura's business is concentrated on its biometric ring products, and therefore it may also face some of its own problems.

DA Davidson, the head of technical research, said, "I will categorize Peloton, GoPro, FitBit, and Oura together. Investors have already suffered significant losses in narrow consumer products, and this is the reaction we are seeing from Oura now. I don't think it necessarily has to do with technology or technological specifications, but rather with the individual consumer products themselves."

Lawyers specializing in public markets say that companies now have more alternative options for financing in the private market than they did in the past, and do not necessarily have to turn to the public market.

Latham and Watkins Capital Market and Listed Companies Business Leader Ian Schuman stated: "The depth of private capital, as well as the alternative options available, are now very substantial and have become more complex and diversified. If you don't obtain the valuation you desire, it's not absolutely necessary for you to enter the public market."

— Gina Francolla Participated in the coverage